Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren pilot study in coronary artery disease and hypertension
2009-015600-26Phase 4Terminated
- Sponsor
- University Hospital Würzburg
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aliskiren in hypertension (HTN) and coronary arteriosclerosis, sponsored by University Hospital Würzburg. Primary endpoints: Change in endothelial function, Change in endothelial progenitor cell number and 2 more. Started Nov 2009; status: terminated.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)coronary arteriosclerosis
Beyond the preview
Go deeper on 2009-015600-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015600-26.